title: Fatal case of community-acquired empyema thoracis and candidemia caused by Candida albicans.
abstract: We report a fatal case of community-acquired empyema thoracis and candidemia caused by Candida albicans. The patient responded poorly to human recombinant activated protein C and intravenous fluconazole treatment and died of profound shock with multiple organ failure 8 days after admission.
authors.affiliation: Department of Internal Medicine, Taoyaun General Hospital, Department of Health, Executive Yuan, Taiwan.
authors.forename: Tzu-Yi
authors.initials: TY
authors.lastname: Chuang
authors.forename: Chien-Yu
authors.initials: CY
authors.lastname: Yeh
authors.forename: Sheng-Wen
authors.initials: SW
authors.lastname: Ko
authors.forename: Chou-Jui
authors.initials: CJ
authors.lastname: Lin
authors.forename: Shin-Wei
authors.initials: SW
authors.lastname: Lee
authors.forename: Po-Ren
authors.initials: PR
authors.lastname: Hsueh
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D002176:Candida albicans / Q000472:pathogenicity*; D058387:Candidemia / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D017714:Community-Acquired Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D004653:Empyema / Q000150:complications / Q000382:microbiology*; D015725:Fluconazole / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D011486:Protein C / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D035423:Thoracic Cavity / Q000382:microbiology* / Q000473:pathology
chemical_list: D000935:Antifungal Agents; D011486:Protein C; D011994:Recombinant Proteins; D015725:Fluconazole; C421124:drotrecogin alfa activated